Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody effector functions are associated with protection from respiratory syncytial virus
Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Cell (2022) Vol. 185, Iss. 26, pp. 4873-4886.e10
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The road to approved vaccines for respiratory syncytial virus
Tracy J. Ruckwardt
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine
Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Victor Augusti Negri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Thi H. O. Nguyen, Louise C. Rowntree, Brendon Y. Chua, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 720-735
Closed Access | Times Cited: 10
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 10
Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
Tyler Brady, Corinne Cayatte, Tiffany Barnes, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Combinatorial Fc modifications for complementary antibody functionality
Yannic C. Bartsch, Nicholas E. Webb, Eleanor Burgess, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice
Youri Lee, Laura Klenow, Elizabeth M. Coyle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial
Tino F. Schwarz, Shinn-Jang Hwang, Pedro Ylisastigui, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. e102-e110
Open Access | Times Cited: 11
ADCC: An underappreciated correlate of cross-protection against influenza?
Rory D. de Vries, Katja Höschler, Guus F. Rimmelzwaan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
Nadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1681-1695.e4
Open Access | Times Cited: 2
Virus neutralization assays for human respiratory syncytial virus using airway organoids
Laura L.A. van Dijk, Laurine C. Rijsbergen, Bruno Tello Rubio, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Sensitive dual-channel lateral flow immunoassay tagged with high brightness latex microsphere for simultaneous detection of respiratory viral antigens
Tao Dong, Guangze Sun, Zhonghuang Yang, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154826-154826
Closed Access | Times Cited: 2
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses
Karlijn van der Straten, Denise Guerra, Gius Kerster, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012453-e1012453
Open Access | Times Cited: 2
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults
Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations
Dicle Yalcin, Sydney J. Bennett, Jared Sheehan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7292-7292
Open Access | Times Cited: 7
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Current state and challenges in respiratory syncytial virus drug discovery and development
Gang Zou, Sushan Cao, Zhao Gao, et al.
Antiviral Research (2023) Vol. 221, pp. 105791-105791
Closed Access | Times Cited: 7
Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults
Anke J. Lakerveld, Anne T. Gelderloos, Rutger M. Schepp, et al.
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 1, pp. 79-93
Open Access | Times Cited: 6
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
Bruno Salaun, Jonathan De Smedt, Charlotte Vernhes, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Antibody‐dependent NK‐cell and neutralizing antibody responses against the Spike protein of Wuhan‐Hu‐1 and Omicron BA.1 SARS‐CoV‐2 variants in vaccinated experienced and vaccinated naïve individuals
Eliseo Albert, Daniel Fernández‐Soto, Estela Giménez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 5
Promyelocytic leukemia zinc finger controls type 2 immune responses in the lungs by regulating lineage commitment and the function of innate and adaptive immune cells
Jia-Feng Sha, Meng Zhang, Jingjing Feng, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111670-111670
Open Access | Times Cited: 1
Impact of SARS-CoV-2 Vaccine and Infection History on Antiviral Immunity Post Breakthrough Infection
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, et al.
(2024)
Closed Access | Times Cited: 1
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques
Xin Tong, Qixin Wang, Wonyeong Jung, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110174-110174
Open Access | Times Cited: 1
Antibodies as key mediators of protection against Mycobacterium tuberculosis
Qixin Wang, Deepika Nag, Susan L. Baldwin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Developing a human monoclonal antibody combination CRM25 to prevent rabies after exposure
Caifeng Long, Wenbo Wang, Jialiang Du, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 6, pp. 107383-107383
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top